Clinical trial
Palbociclib and Binimetinib in Advanced Triple Negative Breast Cancer
NCT04494958
Study timeline
Study start (actual)2020-11-18Date precision: day
Registry last updated2025-03-24
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Triple Negative Breast Cancerunresolved
Interventions
Sponsors & collaborators
Fundacion Oncosurlead sponsor
Pfizercollaborator
Apices Soluciones S.L.collaborator
Pierre Fabre Ibérica, S.A.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04494958 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.